The Saudi Food & Drug Authority is the primary regulatory authority in Saudi Arabia responsible for ensuring the safety, quality, and efficacy of pharmaceuticals and medical devices before they enter the market.
Understanding SFDA requirements is essential for companies aiming to enter or expand within the Saudi healthcare market.
Drug Registration Requirements in Saudi Arabia
Drug registration is conducted through the Saudi Drug Registration (SDR) system, an electronic platform designed to streamline pharmaceutical product approvals.
Key requirements:
- CTD Dossier Submission
Applicants must submit a common technical document (CTD) including:
- Quality data (manufacturing & composition)
- Non-clinical studies
- Clinical studies
- Administrative information
- Quality Compliance
- Good manufacturing practice (GMP)
- Valid certificates from recognized authorities
- Safety & Efficacy Evaluation
- Clinical evidence demonstrating benefit-risk balance
- Labeling Requirements
- Arabic labeling mandatory
- Patient information leaflet (PIL)
- Clear dosage instructions
- Local Agent Requirement
- Foreign companies must appoint a Saudi authorized representative
- Registration Pathways
- Full registration
- Abridged
- Verification pathways
Medical Device Registration Requirements in Saudi Arabia
Medical device regulation in Saudi Arabia follows a risk-based classification system.
Key Requirements:
- Device Classification
Devices are classified into risk categories (Class I-IV), determining regulatory requirements.
- Marketing Authorization (MDMA)
Devices must obtain:
- Medical devices Marketing Authorization (MDMA) or be listed depending on classification
- Technical Documentation
Includes:
- Device description & intended use
- Risk analysis
- Clinical/performance data
- Quality Management System
- ISO 13485 compliance required
- Authorized Representative
- Mandatory for foreign manufacturers
- Registration Systems
- Medical Device National Registry (MDNR)
- Unique Device Identification (UDI) system
- Safety & Performance
- Compliance with essential safety and performance standards
Key Differences Between Drugs and Medical Devices
| Aspect | Drugs | Medical Devices |
| System | SDR | MDMA/MDNR |
| Evidence | Clinical trials | Risk and performance |
| Timeline | Longer | Faster |
| Documentation | CTD | Technical file |
Navigating SFDA regulations requires expertise, precision, and strategic planning. Companies that invest in proper regulatory compliance gain faster market access, improved credibility, and sustainable growth in Saudi Arabia’s rapidly expanding healthcare sector.